Does non-FDA-approved automatically mean illegal abroad?

No. It means the program is not approved by the US Food and Drug Administration for that therapeutic use. Other jurisdictions may operate under different legal and regulatory frameworks.

Can Astramedica guarantee outcomes from a stem cell program?

No. Astramedica does not provide outcome guarantees, and individual results may vary.

Who administers the program?

Programs are administered by independent physicians at partner clinics, not by Astramedica itself.

Does FDA status alone tell a patient whether a program is right for them?

No. Patients should also understand the physician review process, how the program is described, what risks and limits are explained, and the broader regulatory context.

Should patients trust a program more if the marketing language sounds dramatic?

No. Patients are usually better served by precise, careful explanations than by exaggerated or outcome-focused language.

Regulatory Guidance

Are Stem Cell Programs FDA Approved? What Patients Should Know

A compliance-focused explainer on what FDA approval means, why some international stem cell programs are not FDA-approved, and why patients should understand the difference before making decisions.

Key Takeaways

FDA approval has a specific regulatory meaning and should not be implied casually.
Many international stem cell and exosome programs are not FDA-approved for therapeutic use in the United States.
Patients should evaluate the clinic, physician oversight, and regulatory context before proceeding.

When patients research stem cell programs, they often assume every offering has the same regulatory status. That is not the case. In the United States, FDA approval has a specific legal meaning. International programs may operate under different local frameworks and should not be described as FDA-approved unless they truly are.

Back to Blog